132 related articles for article (PubMed ID: 37748679)
1. Characterization of Photon Intensity Modulated Radiation Therapy Robustness in Patients With Prostate Cancer as a Proposed Benchmark for Proton Therapy Robustness Evaluation.
Maas JA; McDonald AM; Cardan RA; Snider JW; Fiveash JB; Kole AJ
Pract Radiat Oncol; 2024; 14(1):e68-e74. PubMed ID: 37748679
[TBL] [Abstract][Full Text] [Related]
2. Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.
Gu W; Ruan D; O'Connor D; Zou W; Dong L; Tsai MY; Jia X; Sheng K
Med Phys; 2019 Mar; 46(3):1408-1425. PubMed ID: 30570164
[TBL] [Abstract][Full Text] [Related]
3. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
[TBL] [Abstract][Full Text] [Related]
5. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
6. Robust mixed electron-photon radiation therapy optimization.
Renaud MA; Serban M; Seuntjens J
Med Phys; 2019 Mar; 46(3):1384-1396. PubMed ID: 30628079
[TBL] [Abstract][Full Text] [Related]
7. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
8. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of OAR dose sparing and plan robustness of beam-specific PTV in lung cancer IMRT treatment.
Chang Y; Xiao F; Quan H; Yang Z
Radiat Oncol; 2020 Oct; 15(1):241. PubMed ID: 33069253
[TBL] [Abstract][Full Text] [Related]
10. Practical robustness evaluation in radiotherapy - A photon and proton-proof alternative to PTV-based plan evaluation.
Korevaar EW; Habraken SJM; Scandurra D; Kierkels RGJ; Unipan M; Eenink MGC; Steenbakkers RJHM; Peeters SG; Zindler JD; Hoogeman M; Langendijk JA
Radiother Oncol; 2019 Dec; 141():267-274. PubMed ID: 31492443
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of robust optimization against geometric uncertainties in TomoHelical planning for prostate cancer.
Yagihashi T; Inoue K; Nagata H; Yamanaka M; Yamano A; Suzuki S; Yamakabe W; Sato N; Omura M; Inoue T
J Appl Clin Med Phys; 2023 Apr; 24(4):e13881. PubMed ID: 36576418
[TBL] [Abstract][Full Text] [Related]
12. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers.
Liu W; Mohan R; Park P; Liu Z; Li H; Li X; Li Y; Wu R; Sahoo N; Dong L; Zhu XR; Grosshans DR
Pract Radiat Oncol; 2014; 4(6):384-91. PubMed ID: 25407859
[TBL] [Abstract][Full Text] [Related]
14. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
Rojo-Santiago J; Korevaar E; Perkó Z; Both S; Habraken SJM; Hoogeman MS
Radiother Oncol; 2023 Sep; 186():109729. PubMed ID: 37301261
[TBL] [Abstract][Full Text] [Related]
15. Automated proton treatment planning with robust optimization using constrained hierarchical optimization.
Taasti VT; Hong L; Deasy JO; Zarepisheh M
Med Phys; 2020 Jul; 47(7):2779-2790. PubMed ID: 32196679
[TBL] [Abstract][Full Text] [Related]
16. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.
Shan J; Sio TT; Liu C; Schild SE; Bues M; Liu W
Med Phys; 2019 Jan; 46(1):382-393. PubMed ID: 30387870
[TBL] [Abstract][Full Text] [Related]
17. Quantification of plan robustness against different uncertainty sources for classical and anatomical robust optimized treatment plans in head and neck cancer proton therapy.
Cubillos-Mesías M; Troost EGC; Lohaus F; Agolli L; Rehm M; Richter C; Stützer K
Br J Radiol; 2020 Mar; 93(1107):20190573. PubMed ID: 31778315
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of dosimetric margins in prostate IMRT treatment plans.
Gordon JJ; Siebers JV
Med Phys; 2008 Feb; 35(2):569-75. PubMed ID: 18383678
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and robustness of dose painting by numbers in proton therapy with contour-driven plan optimization.
Barragán AM; Differding S; Janssens G; Lee JA; Sterpin E
Med Phys; 2015 Apr; 42(4):2006-17. PubMed ID: 25832091
[TBL] [Abstract][Full Text] [Related]
20. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
An Y; Liang J; Schild SE; Bues M; Liu W
Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
